Composition, disintegrative properties, and labeling compliance of commercially available taurine and carnitine dietary products

被引:2
作者
Bragg, Rebecca R. [1 ]
Freeman, Lisa M. [1 ]
Fascetti, Andrea J.
Yu, Zengshou
机构
[1] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA
来源
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2009年 / 234卷 / 02期
关键词
LOW PLASMA TAURINE; DILATED CARDIOMYOPATHY; SUPPLEMENT USE; CARDIAC-DISEASE; UNITED-STATES; TRANSIT-TIME; BODY-SIZE; DOGS; CATS; DEFICIENCY;
D O I
10.2460/javma.234.2.209
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To test the quality, disintegration properties, and compliance with labeling regulations for representative commercially available taurine and carnitine dietary products. Design-Evaluation study. Sample Population-11 commercially available taurine and 10 commercially available carnitine products. Procedures-For each product, the amount of taurine or carnitine was determined and compared with the label claim. All products were evaluated for concentrations of mercury, arsenic, and selenium. Disintegration properties of 5 taurine and 8 carnitine products were determined in vitro. Labels were evaluated for compliance with FDA guidelines. Results-10 of 11 taurine and 10 of 10 carnitine products were within 10% of the stated label claim. Three of 11 taurine and 6 of 10 carnitine products were within 5% of the stated label claim. The median percentage difference between laboratory analysis and label claim was -5.7% (range, -26.3% to 2.5%) for taurine and 3.6% (range, -2.6% to 8.8%) for carnitine. No substantial amount of contamination with mercury, arsenic, or selenium was found in any of the products. During disintegration testing, 1 of 5 taurine products and 5 of 8 carnitine products did not disintegrate within 45 minutes during at least 1 test. Disintegration time for those that did disintegrate ranged from 1.7 to 370 minutes. All product labels conformed with FDA regulations. Conclusions and Clinical Relevance-Taurine and carnitine products evaluated in this study closely adhered to manufacturer claims and labeling guidelines. However, disintegration testing suggested high variability in some products, possibly limiting uptake and use by animals that receive them. (J Am Vet Med Assoc 2009;234:209-213)
引用
收藏
页码:209 / 213
页数:5
相关论文
共 31 条
[1]   Association of dietary supplement use with specific micronutrient intakes among middle-aged American men and women: The INTERMAP Study [J].
Archer, SL ;
Stamler, J ;
Moag-Stahlberg, A ;
Van Horn, L ;
Garside, D ;
Chan, Q ;
Buffington, JJ ;
Dyer, AR .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2005, 105 (07) :1106-1114
[2]  
*ASS AM FEED CONTR, 2008, 2008 OFF PUBL, P131
[3]   Taurine deficiency in Newfoundlands fed commercially available complete and balanced diets [J].
Backus, RC ;
Cohen, G ;
Pion, PD ;
Good, KL ;
Rogers, QR ;
Fascetti, AJ .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 223 (08) :1130-1136
[4]   Low plasma taurine concentration in Newfoundland dogs is associated with low plasma methionine and cyst(e)ine concentrations and low taurine synthesis [J].
Backus, Robert C. ;
Ko, Kwang Suk ;
Fascetti, Andrea J. ;
Kittleson, Mark D. ;
MacDonald, Kristin A. ;
Maggs, David J. ;
Berg, John R. ;
Rogers, Quinton R. .
JOURNAL OF NUTRITION, 2006, 136 (10) :2525-2533
[5]   Vitamin or supplement use among adults, Behavioral Risk Factor Surveillance System, 13 states, 2001 [J].
Balluz, LS ;
Okoro, CA ;
Bowman, BA ;
Serdula, MK ;
Mokdad, AH .
PUBLIC HEALTH REPORTS, 2005, 120 (02) :117-123
[6]   Vitamin and mineral supplement use in the United States -: Results from the third national health and nutrition examination survey [J].
Balluz, LS ;
Kieszak, SM ;
Philen, RM ;
Mulinare, J .
ARCHIVES OF FAMILY MEDICINE, 2000, 9 (03) :258-262
[7]  
*CONS COM, CONS LAB HOM TEST DI
[8]  
FAN AM, 1990, WESTERN J MED, V153, P160
[9]   Taurine deficiency in dogs with dilated cardiomyopathy: 12 cases (1997-2001) [J].
Fascetti, AJ ;
Reed, JR ;
Rogers, QR ;
Backus, RC .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 223 (08) :1137-1141
[10]   Disease prevalence among dogs and cats in the United States and Australia and proportions of dogs and cats that receive therapeutic diets or dietary supplements [J].
Freeman, Lisa M. ;
Abood, Sarah K. ;
Fascetti, Andrea J. ;
Fleeman, Linda M. ;
Michel, Kathryn E. ;
Laflamme, Dorothy P. ;
Bauer, Cassandra ;
Kemp, Brona L. E. ;
Van Doren, Janine R. ;
Willoughby, Kristina N. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2006, 229 (04) :531-534